Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Depreciation & Amortization (CF) (2023 - 2025)

Ardent Health (ARDT) has 3 years of Depreciation & Amortization (CF) data on record, last reported at $39.2 million in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 6.49% year-over-year to $39.2 million; the TTM value through Sep 2025 reached $152.5 million, up 5.61%, while the annual FY2024 figure was $146.3 million, 3.87% up from the prior year.
  • Depreciation & Amortization (CF) reached $39.2 million in Q3 2025 per ARDT's latest filing, roughly flat from $39.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $39.3 million in Q2 2025 and bottomed at $35.4 million in Q1 2024.
  • Average Depreciation & Amortization (CF) over 3 years is $36.9 million, with a median of $36.3 million recorded in 2024.
  • The widest YoY moves for Depreciation & Amortization (CF): up 8.25% in 2025, down 2.4% in 2025.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $36.0 million in 2023, then increased by 5.2% to $37.9 million in 2024, then increased by 3.44% to $39.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $39.2 million in Q3 2025, $39.3 million in Q2 2025, and $36.2 million in Q1 2025.